Baoan Chen Selected Research

Daunorubicin (Cerubidine)

1/2019	Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.
1/2016	Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells.
1/2012	Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line.
1/2012	Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance.
12/2011	Novel Strategy to Fabricate PLA/Au Nanocomposites as an Efficient Drug Carrier for Human Leukemia Cells in Vitro.
3/2011	Rapid diagnosis of multidrug resistance in cancer by electrochemical sensor based on carbon nanotubes-drug supramolecular nanocomposites.
3/2011	Ultrasound mediated drug-loaded nanoparticles crossing cell membranes as a new strategy to reverse cancer multidrug resistance.
1/2011	Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.
1/2011	Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
1/2011	Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baoan Chen Research Topics

Disease

92	Neoplasms (Cancer) 10/2022 - 07/2006
47	Leukemia 12/2022 - 08/2006
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 01/2015
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2009
9	Multiple Myeloma 09/2020 - 11/2010
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 06/2010
8	Lymphoma (Lymphomas) 10/2019 - 11/2010
7	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 06/2010
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 10/2008
5	Colonic Neoplasms (Colon Cancer) 10/2021 - 02/2010
5	Necrosis 01/2017 - 05/2008
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015 - 05/2007
3	Hypoxia (Hypoxemia) 09/2020 - 08/2014
3	Carcinogenesis 01/2020 - 01/2012
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2018 - 01/2014
3	Lung Neoplasms (Lung Cancer) 01/2015 - 01/2009
2	COVID-19 12/2021 - 03/2021
2	Infections 12/2021 - 04/2021
2	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 08/2009
2	Adenocarcinoma of Lung 10/2021 - 01/2020
2	Thrombosis (Thrombus) 01/2021 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2019 - 10/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2017 - 02/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2015 - 01/2011
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2015 - 09/2014
2	Liver Neoplasms (Liver Cancer) 01/2014 - 01/2009
2	Xeroderma Pigmentosum (Kaposi's Disease) 10/2013 - 05/2009
2	Hyperthermia 01/2012 - 02/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012 - 01/2011

Drug/Important Bio-Agent (IBA)

36	Pharmaceutical PreparationsIBA 01/2022 - 07/2006
25	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2019 - 08/2006
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
8	gambogic acidIBA 01/2015 - 01/2009
7	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2022 - 08/2009
6	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019 - 02/2007
6	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 02/2007
6	Caspase 3 (Caspase-3)IBA 01/2019 - 01/2009
5	GoldIBA 11/2018 - 03/2007
5	PlatinumIBA 10/2013 - 05/2009
5	AntigensIBA 11/2010 - 05/2007
4	Tyrosine Kinase InhibitorsIBA 04/2021 - 01/2015
4	Transferrin (beta 2 Transferrin)IBA 01/2019 - 01/2015
4	wogoninIBA 01/2017 - 01/2012
4	SuspensionsIBA 06/2015 - 08/2009
4	Dasatinib (BMS 354825)FDA Link 01/2015 - 10/2008
4	MicroRNAs (MicroRNA)IBA 01/2015 - 01/2014
3	Monoclonal AntibodiesIBA 12/2022 - 01/2019
3	Rituximab (Mabthera)FDA Link 10/2019 - 10/2014
3	Peptides (Polypeptides)IBA 06/2019 - 05/2007
3	Biological ProductsIBA 10/2018 - 04/2010
3	Bortezomib (Velcade)FDA Link 01/2017 - 01/2015
3	neo-gambogic acidIBA 01/2017 - 10/2016
3	ferric oxide (iron oxide)IBA 01/2015 - 01/2011
3	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 06/2007
3	titanium dioxide (Titania)FDA Link 09/2009 - 08/2006
3	NickelIBA 08/2009 - 05/2008
2	tetrandrineIBA 12/2022 - 01/2011
2	Long Noncoding RNAIBA 01/2022 - 10/2021
2	ChromatinIBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 04/2021 - 01/2019
2	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2019 - 10/2014
2	Vincristine (Oncovin)FDA LinkGeneric 10/2019 - 10/2014
2	Prednisone (Sone)FDA LinkGeneric 10/2019 - 10/2014
2	Lysine (L-Lysine)FDA Link 01/2019 - 01/2016
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2019 - 01/2016
2	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2019 - 01/2016
2	IronIBA 11/2018 - 01/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 06/2018 - 01/2014
2	Tumor Biomarkers (Tumor Markers)IBA 05/2018 - 02/2009
2	Dynamin IIIBA 11/2017 - 11/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 11/2010
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2016 - 07/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2016 - 09/2014
2	LigandsIBA 11/2015 - 09/2008
2	Brentuximab VedotinIBA 01/2015 - 01/2015
2	Succimer (Dimercaptosuccinic Acid)FDA Link 01/2015 - 02/2014
2	PolymersIBA 01/2015 - 12/2007
2	Transcription Factors (Transcription Factor)IBA 08/2014 - 01/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 01/2012
2	Arsenic Trioxide (Trisenox)FDA Link 02/2014 - 08/2009
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2014 - 01/2014
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2012 - 06/2010
2	Janus KinasesIBA 06/2012 - 06/2010
2	Drug CarriersIBA 12/2011 - 03/2011
2	EnzymesIBA 02/2010 - 05/2007

Therapy/Procedure

41	Therapeutics 10/2022 - 08/2006
31	Drug Therapy (Chemotherapy) 06/2022 - 08/2006
5	Stem Cell Transplantation 01/2009 - 05/2007
4	Hematopoietic Stem Cell Transplantation 04/2021 - 01/2011
4	Transplantation 01/2020 - 09/2014
4	Aftercare (After-Treatment) 11/2018 - 12/2010
3	Immunotherapy 01/2017 - 06/2007
2	Intraperitoneal Injections 01/2019 - 12/2010
2	Photochemotherapy (Photodynamic Therapy) 06/2016 - 09/2014